ORIC Pharmaceuticals (ORIC) Stock Price, Quote, News & History | Benzinga

ORIC Pharmaceuticals Inc (ORIC) Stock Price, Quote, News & History

ORICNASDAQ

Trade with Public

Trade with Public

$7.57

0.0350.46%

Last update: Jun 9, 11:23 AM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$7.69

Close

-

Volume / Avg.

268.62K / 1.90M

Day Range

$7.56 - $7.87

52 Wk Range

7.23 - 14.93

Market Cap

$783.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

21.42%

Days to Cover

15.39

Recent Oric Pharmaceuticals Inc News

What's Behind The Drop In Oric Pharmaceuticals Stock Today?

Shares of Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) are tumbling Wednesday after the company announced an update from the Phase 1b trial of rinzimetostat in combination with darolutamide in patients with metastatic castration-resistant prostate cancer.

Alex Perry

ORIC Pharmaceuticals Stock Nosedives 25% After Hours: What Is Going On?

ORIC Pharmaceuticals stock rose after reporting positive cancer drug data and advancing to a Phase 3 trial, before falling sharply in after-hours trading.

Tanya Rawat

ORIC Pharmaceuticals Touts Positive Efficacy, Safety Data From Early-Stage Prostate Cancer Candidate, Raises Capital

ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing plans underway.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-110.88M

Investing Cash Flow (TTM)

-188.46M

Financing Cash Flow (TTM)

306.39M

Free Cash Flow (TTM)

-111.20M

Capital Expenditure (TTM)

-327.00K

Net Change in Cash (TTM)

7.06M

Analyst Trends and Forecast

1

Mar

2

Apr

2

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$650.95M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.87

Earnings Yield % (TTM)

-18.48%

Earnings Yield % (FWD)

-18.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.01

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$56.40M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$7.69

Close

-

Volume / Avg.

268.62K / 1.90M

Day Range

$7.56 - $7.87

52 Wk Range

7.23 - 14.93

Market Cap

$783.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

21.42%

Days to Cover

15.39

About

Sector

Health Care

Industry

Biotechnology

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision o...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ORIC Pharmaceuticals (ORIC) stock?

A

You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ORIC Pharmaceuticals (ORIC) competitors?

A

There are no as such competitors for ORIC Pharmaceuticals.

Q

What is the forecast, or price target, for ORIC Pharmaceuticals (ORIC) stock?

A

ORIC Pharmaceuticals has a consensus price target of $20.00.

Q

What is the current price for ORIC Pharmaceuticals (ORIC)?

A

The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $7.565 last updated June 9, 2026 at 11:23 AM EDT.

Q

Does ORIC Pharmaceuticals (ORIC) pay a dividend?

A

There are no upcoming dividends for ORIC Pharmaceuticals.

Q

When is ORIC Pharmaceuticals (NASDAQ:ORIC) reporting earnings?

A

ORIC Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is ORIC Pharmaceuticals (ORIC) going to split?

A

There is no upcoming split for ORIC Pharmaceuticals.

Q

What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?

A

ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.